Great result. No debt. Plenty of cash rolling in the door and out to shareholder for dividends and buybacks.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025